<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurology</journal-id>
<journal-id journal-id-type="hwp">neurology</journal-id>
<journal-id journal-id-type="publisher-id">neur</journal-id>
<journal-id journal-id-type="pmc">neurology</journal-id>
<journal-id journal-id-type="publisher-id">NEUROLOGY</journal-id>
<journal-title-group>
<journal-title>Neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0028-3878</issn>
<issn pub-type="epub">1526-632X</issn>
<publisher>
<publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
<publisher-loc>Hagerstown, MD</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26674333</article-id>
<article-id pub-id-type="pmc">4731688</article-id>
<article-id pub-id-type="publisher-id">NEUROLOGY2015657247</article-id>
<article-id pub-id-type="doi">10.1212/WNL.0000000000002263</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>2</subject>
<subject>25</subject>
<subject>91</subject>
<subject>95</subject>
<subject>120</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Traylor</surname>
<given-names>Matthew</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="author-notes" rid="fn1">*</xref>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Cathy R.</given-names>
</name>
<degrees>MA</degrees>
<xref ref-type="author-notes" rid="fn1">*</xref>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adib-Samii</surname>
<given-names>Poneh</given-names>
</name>
<degrees>MBBS</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>I was awarded Medical Research Council (UK) Clinical Training Fellowship 2010 to 2013</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Devan</surname>
<given-names>William J.</given-names>
</name>
<degrees>BS</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parsons</surname>
<given-names>Owen E.</given-names>
</name>
<degrees>MSc</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lanfranconi</surname>
<given-names>Silvia</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gregory</surname>
<given-names>Sarah</given-names>
</name>
<degrees>PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cloonan</surname>
<given-names>Lisa</given-names>
</name>
<degrees>BA</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Falcone</surname>
<given-names>Guido J.</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NINDS, Grant number P50NS061343, research fellow, 2013.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Radmanesh</surname>
<given-names>Farid</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fitzpatrick</surname>
<given-names>Kaitlin</given-names>
</name>
<degrees>BSc</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanakis</surname>
<given-names>Allison</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrick</surname>
<given-names>Thomas R.</given-names>
</name>
<degrees>PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moynihan</surname>
<given-names>Barry</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for travel or speaker honoraria:</title>
<list-item>
<p>(1) Pfizer, Honoraria for speaking engagements</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Cathryn M.</given-names>
</name>
<degrees>PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>(1) Human Heredity - Associate editor - 2005 onwards (2) PLOS Medicine - Academic editor - 2004 onwards</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boncoraglio</surname>
<given-names>Giorgio B.</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lemmens</surname>
<given-names>Robin</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>FWO Flanders: Senior Clinical Investigator, 2012-2017, 1841913N FWO Flanders: Research Grant 2015-2019: basic science grant no role in this study G070015N</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thijs</surname>
<given-names>Vincent</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>(1)Sygnis Ax200 steering committee (2) Boehringer Ingelheim Belgium advisory board (3) Boehringer Ingelheim international advisory board (4) Medtronic steering committee of the REACT-AF trial</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for travel or speaker honoraria:</title>
<list-item>
<p>(1) Medtronic (2) Boehringer Ingelheim (3) Pfizer (4) Bayer</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>Acta Neurologica Belgica, Associate Editor, ongoing Stroke Editorial board member, ongoing European Journal of Emergency Medicine, Editorial Board member, ongoing</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>(1) Boehringer Ingelheim (2) Pfizer (3) Bayer (4) Astra Zeneca (5) Medtronic</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>Pfizer Inc Boehringer Ingelheim Medtronic</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>SYGNIS AG, Medtronic, Inc., Pfizer Inc., AstraZeneca, Boehringer Ingelheim, Astra Zeneca</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>VIB Flanders Research Fund (FWO)</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>Flanders Research Fund (FWO)</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sudlow</surname>
<given-names>Cathie</given-names>
</name>
<degrees>MD, PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>(1) UK MRC, UK Biobank programme renewal, ?35 million, 2010-2017 (co-applicant) (2) UK MRC, Dementias Platform UK programme grant, ?12 million, 2014-2019 (co-applicant)</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>(1) British Heart Foundation 2012-2017 RESTART trial of antiplatelet treatment in ICH ( co- applicant) (2) UKBiobank 01/05/2012-ongoing Stroke Outcomes Pilot (principal applicant) (3) UK Biobank 01/09/2012-ongoing chief scientist support (principal applicant) (4) NIH via University of Maryland Stroke GWAS sub award for stroke phenotyping 01/06/2011-31/12/2013</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wardlaw</surname>
<given-names>Joanna</given-names>
</name>
<degrees>FMedSci</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>Stroke, Editorial Board, ended August 2013; International Journal of Stroke 2014 onwards</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>Boehringer-Ingelheim GmbH donated drug and placebo for the 300 patients in the double-blind phase of IST-3, but thereafter had no role whatsoever in the trial.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>Medical Research Council. ?Centre in Cognitive Ageing and Cognitive Epidemiology?, ?3,413,977 FEC over five years from August 2008. Renewed Sept 2013 ? Aug 2018. I Deary (Centre head), R Logie, J Seckl, J McCulloch, D Porteous, J Wardlaw (Imaging lead). Medical Research Council. ?Brain white matter imaging and cognitive ageing in the Lothian Birth Cohort of 1936:II.? ?764,304, 1st April 2011-31st Mar 2015. Prof IJ Deary (PI), Prof JM Wardlaw, Dr M Bastin, Prof J Starr. EU Joint Programme - Neurodegenerative Disease Research. ?Realising the potential of cohort studies to determine the vascular contribution to neurodegeneration?, ?47,416, 1st Oct 2014 to 31st Mar 2015. J Wardlaw, Medical Research Council. ?Brain white matter imaging and cognitive ageing in the Lothian Birth Cohort of 1936:III? ?1,300,000 (FEC), 31st Mar 2015 to 28th Feb 2019. IJ Deary (PI), JM Wardlaw, J Starr, M Bastin. Technology Strategy Board. ?Quantification of vascular disease burden to stratify dementia for diagnosis and care management?, ?1,048,661 (?306,946 to Edinburgh), 1st Apr 2015 to 31st Mar 2017. R Wolz (Ixico Technologies Ltd.), D Rueckert, J Wardlaw.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>Scottish Funding Council SPIRIT Scheme. ?Novel and collaborative approaches to knowledge exchange in translational imaging?, ?1,124,928 - 1st Apr 2010-31st Dec 2014. Professor J Wardlaw, Dr J DeWilde, Dr A Murray, Dr R Lerski, Dr J Owen. Ref No. HR09021. SFC: SINAPSE-2 Continued development of the SINAPSE Network?, ?325,000, 31st Oct 2014 to 30th Sep 2019. D Wyer, J Wardlaw, A Murray, D Lerski, K Muir, D Donaldson, A O?Connor. EPSRC. ?Multi-modal retinal biomarkers for vascular dementia: developing enabling image analysis tools.? ?1,100,000, 1st Apr 2015 to 31st Mar 2018. E Trucco, J Wardlaw, T MacGillivray, F Doubal, I Deary, A Doney.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>The Row Fogo Trust. ?Research studies in stroke and other common brain diseases?, ?400,000, 1st Apr 2001 to 31st Jul 2009. ?316,000 extension until 2014. Renewed to 2018 ?380,000. Dr JM Wardlaw, Dr I Marshall, Dr M Bastin and the Stroke Research Group. Ref No: AD.ROW4.35, R35865. Age UK. ?The Disconnected Mind?, ?2,500,000 over 5 years from 1st April 2011. Deary, I.J., &amp; Starr, J.M., &amp; Wardlaw, J.M.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rothwell</surname>
<given-names>Peter M.</given-names>
</name>
<degrees>FMedSci</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>Bayer - Executive Committee of ARRIVE Trial - 2006 onwards Servier - Executive Committee of PERFORM trial - 2005 -2010 Pfizer - IDMC if Rocket-AF Trial - 2006 - 2009 Biotronic - Executive Committee of device trial - 2005 - 2011</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for travel or speaker honoraria:</title>
<list-item>
<p>I don't keep a record. Certainly had travel expenses paid by Sanofi-Aventis, Servier, Astra-Zeneca and Bayer in past. However, nothing relevant to this manuscript.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>Editorial Board - Lancet Neurology, International Journal of Stroke</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meschia</surname>
<given-names>James F.</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>On the editorial boards of Mayo Clinic Proceedings, Stroke, and the European Journal of Neurology.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>Dr. Meschia receives support from the NINDS for efforts devoted to the SiGN study.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Worrall</surname>
<given-names>Bradford B.</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>Neurology: Associate Editor 1 July 2009 - present Seminars in Neurology Editorial Board 2006-2014</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>Chapter Author for Merritt's Neurology editions 10, 11, and 12.</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NINDS/NIH - R01 NS 069763 (co-investigator) 2010-2016 NINDS/NIH ? U-01 NS069208 (co-Prinicpal Investigator) 2010-2015 NHGRI/NIH ? U-01 HG005160 (co-Principal Investigator) 2009-2014</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>University of Virginia - CENETERS OF EXCELLENCE CLINICAL RESEARCH GRANT SUPPORT - The UVA BRAIN AND AORTIC ANEURYSM SCREENING (BAAS) study - Principal Investigator 10/13-9/15</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Levi</surname>
<given-names>Christopher</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>Apixaban Scientific Advisory Board - Pfizer National Stroke Foundation (Australia) Research Advisory Committee</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for travel or speaker honoraria:</title>
<list-item>
<p>Received travel expenses and/or honoraira for lectures or educational activities not funded by industry</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>Advisory Board - Medicine Today, Since 2009 Associate Editor - BMC Neurology, Since 2011</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>Expert External Reviewer - Stroke and Neurology Service, The Alfred Hospital, Melbourne. 2012</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NHMRC Practitioner Fellowship 2013-17 NHMRC Project and Partnership Grants 2000-2017 Australian Brain Foundation Project Grants</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>National Stroke Foundation, Australia</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bevan</surname>
<given-names>Steve</given-names>
</name>
<degrees>PhD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Furie</surname>
<given-names>Karen L.</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>DSMB for NINDS Adjudication committee for NHLBI sponsored CTSN DSMB for Pfizer</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>I am the Vice Editor of Stroke I am Deputy Editor of Journal of Neurology, Neurosurgery, and Psychiatry</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>I receive royalties from UpToDate</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>Non profit: The Neurology Foundation, Inc</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NINDS</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>American Heart Association</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dichgans</surname>
<given-names>Martin</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for travel or speaker honoraria:</title>
<list-item>
<p>(1) Bayer Vital, (2) Boehringer Ingelheim, (3) Bristol- Meyer Squibb</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>(1) Stroke the International Journal of Stroke, editor, (2) Cerebrovascular diseases, editorial board member, (3) Journal of Neurochemistry, editor</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>(1) Bayer Vital, (2) Boehringer Ingelheim, (3) Bristol- Meyer Squibb</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>(1) Wellcometrust, 03/08 following, (2) European Union (EU FP 7), investigator, 10/13-09/16, (3) German Federal Ministry of Education and Research (BMBF), investigator, 12/13-11/16, (4) European Union (EU FP 6), investigator, 03/12-02/15</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>(1) Vascular Dementia Research Foundation, (2) Corona Foundation, (3) Jackst?dt Foundation</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosand</surname>
<given-names>Jonathan</given-names>
</name>
<degrees>MD</degrees>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>Lancet Neurology, editorial board member Stroke, editorial board member</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>Boehringer Ingelheim</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NINDS, R01NS059727 NINDS, R01NS073344 NINDS, U01NS069208 NINDS, U01NS069763</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>Boehringer Ingelheim, consultant</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Markus</surname>
<given-names>Hugh S.</given-names>
</name>
<degrees>DM</degrees>
<xref ref-type="author-notes" rid="fn1">*</xref>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for Travel or Speaker Honoraria:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>Section editor International Journal of stroke editorial board Clin Neurology and Neurosurgery and BMC Medicine</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>Stroke Medicine OUP. 2010</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>Wellcome Trust for the SCANS study ARUK for our work on network analysis</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>Stroke Association, EU, Wellcome Trust, The British Heart Foundation, Alzheimer Research for peer reviewed research grants</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rost</surname>
<given-names>Natalia</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="author-notes" rid="fn1">*</xref>
<author-comment content-type="disclosure">
<p>
<list list-type="order">
<title>Scientific Advisory Boards:</title>
<list-item>
<p>(1)Genzyme Co., (2) Daiichi Sankyo, (3) Merck, (4) Boston Biomedical Associates, (5) Omniox</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Gifts:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Funding for travel or speaker honoraria:</title>
<list-item>
<p>Daiichi Sankyo, travel/speaker honoraria</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Editorial Boards:</title>
<list-item>
<p>(1) Stroke, Assistant Editor, 2010 - (2) Current Treatment Options in Cardiovascular Medicine, Section Editor, 2014 -</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Patents:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Publishing Royalties:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Employment, Commercial Entity:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Consultancies:</title>
<list-item>
<p>(1)Genzyme Co., (2) Daiichi Sankyo, (3) Merck, (4) Boston Biomedical Associates, (5) Omniox</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Speakers' Bureaus:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Other Activities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Clinical Procedures or Imaging Studies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Commercial Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Government Entities:</title>
<list-item>
<p>NIH/NINDS K23NS064052 (PI), 2009-2014 NIH/NINDS R01NS082285 (PI), 2013 -current NIH/NINDS R01NS086905 (PI), 2015 - current</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Academic Entities:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Research Support, Foundations and Societies:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options/Board of Directors Compensation:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>License Fee Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Royalty Payments, Technology or Inventions:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Research Sponsor:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Stock/Stock Options, Medical Equipment &amp; Materials:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
<p>
<list list-type="order">
<title>Legal Proceedings:</title>
<list-item>
<p>NONE</p>
</list-item>
</list>
</p>
</author-comment>
</contrib>
<on-behalf-of>On behalf of the International Stroke Genetics Consortium</on-behalf-of>
<aff>Authors' affiliations are listed at the end of the article.</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="collab">
<collab>International Stroke Genetics Consortium</collab>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Smoller</surname>
<given-names>Sylvia</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sorkin</surname>
<given-names>John</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Wang</surname>
<given-names>Xingwu</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Selim</surname>
<given-names>Magdy</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Pikula</surname>
<given-names>Aleksandra</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Wolf</surname>
<given-names>Philip</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Debette</surname>
<given-names>Stephanie</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Seshadri</surname>
<given-names>Sudha</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>de Bakker</surname>
<given-names>Paul</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chasman</surname>
<given-names>Daniel</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rexrode</surname>
<given-names>Kathryn</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chen</surname>
<given-names>Ida</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rotter</surname>
<given-names>Jerome</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Luke</surname>
<given-names>May</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sale</surname>
<given-names>Michelle</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lee</surname>
<given-names>Tsong-Hai</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chang</surname>
<given-names>Ku-Chou</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Elkind</surname>
<given-names>Mitchell</given-names>
</name>
<degrees>MD, MS</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Goldstein</surname>
<given-names>Larry</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>James</surname>
<given-names>Michael (Luke)</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Breteler</surname>
<given-names>Monique</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>O'Donnell</surname>
<given-names>Chris</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Leys</surname>
<given-names>Didier</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Carty</surname>
<given-names>Cara</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kidwell</surname>
<given-names>Chelsea</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Olesen</surname>
<given-names>Jes</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sharma</surname>
<given-names>Pankaj</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rich</surname>
<given-names>Stephen</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Tatlisumak</surname>
<given-names>Turgot</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Happola</surname>
<given-names>Olli</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Bijlenga</surname>
<given-names>Philippe</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Soriano</surname>
<given-names>Carolina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Giralt</surname>
<given-names>Eva</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Roquer</surname>
<given-names>Jaume</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Jimenez-Conde</surname>
<given-names>Jordi</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Cotlarcius</surname>
<given-names>Ioana</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Hardy</surname>
<given-names>John</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Korostynski</surname>
<given-names>Michal</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Boncoraglio</surname>
<given-names>Giorgio</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Ballabio</surname>
<given-names>Elena</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Parati</surname>
<given-names>Eugenio</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Mateusz</surname>
<given-names>Adamski</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Urbanik</surname>
<given-names>Andrzej</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Dziedzic</surname>
<given-names>Tomasz</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Jagiella</surname>
<given-names>Jeremiasz</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Gasowski</surname>
<given-names>Jerzy</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Wnuk</surname>
<given-names>Marcin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Olszanecki</surname>
<given-names>Rafał</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Pera</surname>
<given-names>Joanna</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Slowik</surname>
<given-names>Agnieszka</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Juchniewicz</surname>
<given-names>Karol Józef</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Levi</surname>
<given-names>Christopher</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Nyquist</surname>
<given-names>Paul</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Cendes</surname>
<given-names>Iscia</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Cabral</surname>
<given-names>Norberto</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Franca</surname>
<given-names>Paulo</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Goncalves</surname>
<given-names>Anderson</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Keller</surname>
<given-names>Lina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Crisby</surname>
<given-names>Milita</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kostulas</surname>
<given-names>Konstantinos</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lemmens</surname>
<given-names>Robin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Ahmadi</surname>
<given-names>Kourosh</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Opherk</surname>
<given-names>Christian</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Duering</surname>
<given-names>Marco</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Dichgans</surname>
<given-names>Martin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Malik</surname>
<given-names>Rainer</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Gonik</surname>
<given-names>Mariya</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Staals</surname>
<given-names>Julie</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Melander</surname>
<given-names>Olle</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Burri</surname>
<given-names>Philippe</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sadr-Nabavi</surname>
<given-names>Ariane</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Romero</surname>
<given-names>Javier</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Biffi</surname>
<given-names>Alessandro</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Anderson</surname>
<given-names>Chris</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Falcone</surname>
<given-names>Guido</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Brouwers</surname>
<given-names>Bart</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rosand</surname>
<given-names>Jonathan</given-names>
</name>
<degrees>MD, MSc</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rost</surname>
<given-names>Natalia</given-names>
</name>
<degrees>MD, MSc</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Du</surname>
<given-names>Rose</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kourkoulis</surname>
<given-names>Christina</given-names>
</name>
<degrees>BA</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Battey</surname>
<given-names>Thomas</given-names>
</name>
<degrees>BA</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lubitz</surname>
<given-names>Steven</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Mueller-Myhsok</surname>
<given-names>Bertram</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Meschia</surname>
<given-names>James</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Brott</surname>
<given-names>Thomas</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Pare</surname>
<given-names>Guillaume</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Pichler</surname>
<given-names>Alexander</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Enzinger</surname>
<given-names>Christian</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Schmidt</surname>
<given-names>Helena</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Schmidt</surname>
<given-names>Reinhold</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Seiler</surname>
<given-names>Stephan</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Blanton</surname>
<given-names>Susan</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Yamada</surname>
<given-names>Yoshiji</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Bersano</surname>
<given-names>Anna</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rundek</surname>
<given-names>Tatjana</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sacco</surname>
<given-names>Ralph</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Yvonne Chan</surname>
<given-names>Yu-Feng</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Gschwendtner</surname>
<given-names>Andreas</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Deng</surname>
<given-names>Zhen</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Barr</surname>
<given-names>Taura</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Gwinn</surname>
<given-names>Katrina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Corriveau</surname>
<given-names>Roderick</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Singleton</surname>
<given-names>Andrew</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Waddy</surname>
<given-names>Salina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Launer</surname>
<given-names>Lenore</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chen</surname>
<given-names>Christopher</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Le</surname>
<given-names>Kim En</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lee</surname>
<given-names>Wei Ling</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Tan</surname>
<given-names>Eng King</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Olugbodi</surname>
<given-names>Akintomi</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rothwell</surname>
<given-names>Peter</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Schilling</surname>
<given-names>Sabrina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Mok</surname>
<given-names>Vincent</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lebedeva</surname>
<given-names>Elena</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Jern</surname>
<given-names>Christina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Jood</surname>
<given-names>Katarina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Olsson</surname>
<given-names>Sandra</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kim</surname>
<given-names>Helen</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lee</surname>
<given-names>Chaeyoung</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kilarski</surname>
<given-names>Laura</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Markus</surname>
<given-names>Hugh</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Peycke</surname>
<given-names>Jennifer</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Bevan</surname>
<given-names>Steve</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sheu</surname>
<given-names>Wayne</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chiou</surname>
<given-names>Hung Yi</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chern</surname>
<given-names>Joseph</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Giraldo</surname>
<given-names>Elias</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Taqi</surname>
<given-names>Muhammad</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Jain</surname>
<given-names>Vivek</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lam</surname>
<given-names>Olivia</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Howard</surname>
<given-names>George</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Woo</surname>
<given-names>Daniel</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kittner</surname>
<given-names>Steven</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Mitchell</surname>
<given-names>Braxton</given-names>
</name>
<degrees>PhD, MPH</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Cole</surname>
<given-names>John</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>O'Connell</surname>
<given-names>Jeff</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Milewicz</surname>
<given-names>Dianna</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Illoh</surname>
<given-names>Kachikwu</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Worrall</surname>
<given-names>Bradford</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Stine</surname>
<given-names>Colin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Karaszewski</surname>
<given-names>Bartosz</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Werring</surname>
<given-names>David</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sofat</surname>
<given-names>Reecha</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Smalley</surname>
<given-names>June</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lindgren</surname>
<given-names>Arne</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Hansen</surname>
<given-names>Bjorn</given-names>
</name>
<degrees>BA</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Norrving</surname>
<given-names>Bo</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Smith</surname>
<given-names>Gustav</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Martín</surname>
<given-names>Juan José</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Thijs</surname>
<given-names>Vincent</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Klijn</surname>
<given-names>Karin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>van't Hof</surname>
<given-names>Femke</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Algra</surname>
<given-names>Ale</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Macleod</surname>
<given-names>Mary</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Perry</surname>
<given-names>Rodney</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Arnett</surname>
<given-names>Donna</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Pezzini</surname>
<given-names>Alessandro</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Padovani</surname>
<given-names>Alessandro</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Cramer</surname>
<given-names>Steve</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Fisher</surname>
<given-names>Mark</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Saleheen</surname>
<given-names>Danish</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Broderick</surname>
<given-names>Joseph</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kissela</surname>
<given-names>Brett</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Doney</surname>
<given-names>Alex</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sudlow</surname>
<given-names>Cathie</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Rannikmae</surname>
<given-names>Kristiina</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Silliman</surname>
<given-names>Scott</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>McDonough</surname>
<given-names>Caitrin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Walters</surname>
<given-names>Matthew</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Pedersen</surname>
<given-names>Annie</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Nakagawa</surname>
<given-names>Kazuma</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chang</surname>
<given-names>Christy</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Dobbins</surname>
<given-names>Mark</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>McArdle</surname>
<given-names>Patrick</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Chang</surname>
<given-names>Yu-Ching</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Brown</surname>
<given-names>Robert</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Brown</surname>
<given-names>Devin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Holliday</surname>
<given-names>Elizabeth</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Kalaria</surname>
<given-names>Raj</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Maguire</surname>
<given-names>Jane</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Attia</surname>
<given-names>John</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Farrall</surname>
<given-names>Martin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Giese</surname>
<given-names>Anne-Katrin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Fornage</surname>
<given-names>Myriam</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Majersik</surname>
<given-names>Jennifer</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Cushman</surname>
<given-names>Mary</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Keene</surname>
<given-names>Keith</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Bennett</surname>
<given-names>Siiri</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Tirschwell</surname>
<given-names>David</given-names>
</name>
<degrees>MD, MSc</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Psaty</surname>
<given-names>Bruce</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Reiner</surname>
<given-names>Alex</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Longstreth</surname>
<given-names>Will</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Spence</surname>
<given-names>David</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Montaner</surname>
<given-names>Joan</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Fernandez-Cadenas</surname>
<given-names>Israel</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Langefeld</surname>
<given-names>Carl</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Bushnell</surname>
<given-names>Cheryl</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Heitsch</surname>
<given-names>Laura</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Lee</surname>
<given-names>Jin-Moo</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="collab">
<name>
<surname>Sheth</surname>
<given-names>Kevin</given-names>
</name>
<degrees>MD</degrees>
</contrib>
</contrib-group>
<author-notes>
<corresp>Correspondence to Dr. Traylor: <email>mt628@medschl.cam.ac.uk</email></corresp>
<fn fn-type="other" id="fn1">
<label>*</label>
<p>These authors contributed equally to this work.</p>
</fn>
<fn fn-type="other">
<p>Coinvestigators are listed on the <italic>Neurology</italic>® Web site at <ext-link ext-link-type="uri" xlink:href="http://neurology.org/lookup/doi/10.1212/WNL.0000000000002263">Neurology.org</ext-link>.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>Go to <ext-link ext-link-type="uri" xlink:href="http://neurology.org/lookup/doi/10.1212/WNL.0000000000002263">Neurology.org</ext-link> for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The Article Processing Charge was paid by Wellcome Trust.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>12</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>1</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="ppub"/>. -->
<volume>86</volume>
<issue>2</issue>
<fpage>146</fpage>
<lpage>153</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>4</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>9</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© 2015 American Academy of Neurology</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>American Academy of Neurology</copyright-holder>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri xlink:href="NEUROLOGY2015657247.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<sec>
<title>Objective:</title>
<p>For 3,670 stroke patients from the United Kingdom, United States, Australia, Belgium, and Italy, we performed a genome-wide meta-analysis of white matter hyperintensity volumes (WMHV) on data imputed to the 1000 Genomes reference dataset to provide insights into disease mechanisms.</p>
</sec>
<sec>
<title>Methods:</title>
<p>We first sought to identify genetic associations with white matter hyperintensities in a stroke population, and then examined whether genetic loci previously linked to WMHV in community populations are also associated in stroke patients. Having established that genetic associations are shared between the 2 populations, we performed a meta-analysis testing which associations with WMHV in stroke-free populations are associated overall when combined with stroke populations.</p>
</sec>
<sec>
<title>Results:</title>
<p>There were no associations at genome-wide significance with WMHV in stroke patients. All previously reported genome-wide significant associations with WMHV in community populations shared direction of effect in stroke patients. In a meta-analysis of the genome-wide significant and suggestive loci (<italic>p</italic> &lt; 5 × 10<sup>−6</sup>) from community populations (15 single nucleotide polymorphisms in total) and from stroke patients, 6 independent loci were associated with WMHV in both populations. Four of these are novel associations at the genome-wide level (rs72934505 [<italic>NBEAL1</italic>], <italic>p</italic> = 2.2 × 10<sup>−8</sup>; rs941898 [<italic>EVL</italic>], <italic>p</italic> = 4.0 × 10<sup>−8</sup>; rs962888 [<italic>C1QL1</italic>], <italic>p</italic> = 1.1 × 10<sup>−8</sup>; rs9515201 [<italic>COL4A2</italic>], <italic>p</italic> = 6.9 × 10<sup>−9</sup>).</p>
</sec>
<sec>
<title>Conclusions:</title>
<p>Genetic associations with WMHV are shared in otherwise healthy individuals and patients with stroke, indicating common genetic susceptibility in cerebral small vessel disease.</p>
</sec>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>OPEN-ACCESS</meta-name>
<meta-value>TRUE</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body><p>White matter hyperintensities (WMH) on T2-weighted MRI are associated with increasing age and cardiovascular risk factors, particularly hypertension, and are predictive of both stroke and dementia in prospective community populations.<sup><xref ref-type="bibr" rid="R1">1</xref></sup> Severe confluent WMH are often found in patients presenting with stroke, and are more common in patients with the small vessel stroke subtype.<sup><xref ref-type="bibr" rid="R2">2</xref></sup> Furthermore, in these patients, WMH burden is linked to poor clinical outcomes after stroke.<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref></sup> Understanding disease mechanisms that contribute to WMH could lead to advances in prevention, treatment, and rehabilitation of disability related to vascular cognitive impairment, age-related functional decline, and stroke.</p><p>Twin and family history studies suggest a significant genetic component to WMH. Heritability estimates range from 55% to 80%,<sup><xref ref-type="bibr" rid="R5">5</xref><xref ref-type="bibr" rid="R6">–</xref><xref ref-type="bibr" rid="R8">8</xref></sup> suggesting that a moderate to large proportion of the disease risk can be attributed to genetic effects. The heritability attributed to common single nucleotide polymorphisms (SNPs) has been estimated to be between 13% and 45%.<sup><xref ref-type="bibr" rid="R9">9</xref></sup> Previous genome-wide analyses have focused on the genetic influence on WMH in community populations,<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref></sup> and a recent meta-analysis identified 8 regions associated with the disease.<sup><xref ref-type="bibr" rid="R12">12</xref></sup> One might expect genetic risk factors for WMH in community populations to be similar to those that confer increased risk of WMH in stroke patients. However, the underlying pathology of WMH is heterogeneous, with small punctate lesions being associated with mixed causes, whereas more confluent areas often seen in stroke patients correspond primarily to small vessel disease.<sup><xref ref-type="bibr" rid="R13">13</xref></sup> Therefore, it is unclear whether the lesions underlying WMH in the general population are pathologically distinct from the confluent lesions frequently observed in patients with stroke.</p><p>In this analysis, we investigated the role of the genetic contribution to WMH volumes (WMHV) in patients with ischemic stroke. We initially performed a genome-wide meta-analysis of WMHV in stroke patients with the aim of identifying novel associations. Second, we determined whether similar genetic factors contributed to WMHV in community populations and stroke patients. Finally, having established shared genetic factors in the 2 datasets, we performed a meta-analysis of the published associations from community populations with our dataset to identify genetic associations that are in common in the 2 populations.</p><sec id="s1" sec-type="methods"><title>METHODS</title><sec id="s1-1"><title>Study populations.</title><p>Ischemic stroke populations were enrolled through hospital-based studies between 1995 and 2013. Characteristics of the study populations are given in <xref ref-type="table" rid="T1">table 1</xref>; full details are given in the supplementary material on the <italic>Neurology</italic>® Web site at <ext-link ext-link-type="uri" xlink:href="http://neurology.org/lookup/doi/10.1212/WNL.0000000000002263">Neurology.org</ext-link>. Patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy or any other suspected monogenic cause of stroke, vasculitis, or any other nonischemic cause of WMH including demyelinating and mitochondrial disorders were excluded from analyses.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Cohort characteristics</p></caption><graphic xlink:href="NEUROLOGY2015657247TT1"></graphic></table-wrap></sec><sec id="s1-2"><title>Standard protocol approvals, registrations, and patient consents.</title><p>An institutional review board or regional review board approved the use of human subjects in each of the study populations. All patients gave informed consent.</p></sec><sec id="s1-3"><title>Neuroimaging analysis.</title><p>MRI scans were acquired as part of routine clinical practice for evaluation of ischemic stroke (table e-1). Fluid-attenuated inversion recovery (FLAIR) sequences were primarily used for WMH volumetric analysis; however, in their absence, T2-weighted sequences were used (Wellcome Trust Case Control Consortium–2 [WTCCC2], Oxford, and WTCCC2, Munich, only). In all scans, to avoid confounding by hyperintense signal due to acute stroke, WMHV was assessed quantitatively in the hemisphere contralateral to the acute infarction. Chronic lacunar infarcts were identified using standard criteria as low signal on T1 or FLAIR images and were excluded from WMHV estimates.<sup><xref ref-type="bibr" rid="R14">14</xref></sup> Trained raters blinded to all patient information analyzed anonymized MRI scans. All supratentorial white matter and deep gray matter lesions were included in WMHV with the exception of WMH corresponding to infarcts, both lacunar and territorial.<sup><xref ref-type="bibr" rid="R2">2</xref></sup> MRIs with excessive movement artefact, incomplete brain coverage, or bihemispheric infarcts (other than lacunar) were excluded.</p><p>To account for interindividual variability in head size, an estimate of total intracranial volume (TICV) was derived using site-specific volumetric methodology, as follows. MRIs from the Massachusetts General Hospital, Ischemic Stroke Genetics Study, and Australian Stroke Genetics Collaborative studies were analyzed in Boston. Scans from the Siblings with Ischaemic Stroke Study were analyzed in the same way at the University of Virginia by the Boston-trained rater. FLAIR sequences were analyzed using an MRIcro semiautomated method as previously described.<sup><xref ref-type="bibr" rid="R2">2</xref></sup> Using operator-mediated quality assurances, overlapping regions of interest (ROIs) corresponding to WMH produced the final maps for WMHV calculation. Intracranial area was derived as a validated marker of TICV as the average of 2 midsagittal slices traced using anatomical landmarks on T1 sequences.<sup><xref ref-type="bibr" rid="R15">15</xref></sup></p><p>The WTCCC2, GENESIS, SGUL, Leuven, and Milan cohorts were analyzed in London using DISPunc semiautomated lesion drawing software.<sup><xref ref-type="bibr" rid="R16">16</xref></sup> A seed at the lesion border was first marked manually, and then outlined automatically based on the signal intensity gradient. Each WMH ROI was visually inspected and manually corrected as required. To estimate TICV, T2-weighted and, in their absence, FLAIR sequences were analyzed using an automated segmentation program, SIENAX,<sup><xref ref-type="bibr" rid="R17">17</xref></sup> which calculates the total volume of CSF and gray and white matter volumes.</p><p>WMHV quantification agreement across the 2 main rating centers was performed for 50 randomly selected scans; agreement was very good (intraclass correlation coefficient 0.95, confidence interval 0.91–0.97, n = 50).</p></sec><sec id="s1-4"><title>Phenotype definition.</title><p>To calculate the phenotype used in the genetic analysis, WMHV were doubled to obtain a whole brain estimate. This volume was then multiplied by the ratio of TICV (or intracranial area) to the mean TICV (or intracranial area) for the study, thereby correcting for natural differences in head size. The values were natural log transformed and the resulting ln (WMHV) values were entered into a linear regression model including age, sex, and the first 2 ancestry-informative principal components. To ensure the phenotype was normally distributed, the residuals from the model were then <italic>z</italic>-transformed and used as the WMHV phenotype in the genetic analysis.</p></sec><sec id="s1-5"><title>Genome-wide genotyping and imputation.</title><p>Genotyping of all cohorts was performed on commercially available arrays from Affymetrix (Santa Clara, CA) or Illumina (San Diego, CA) (table e-2). All cohorts performed extensive quality control steps prior to imputation, removing SNPs showing significant departure from Hardy-Weinberg equilibrium, high levels of missingness, or low minor allele frequency. Individuals were removed who did not segregate with Hapmap II European populations based on ancestry informative principal component analysis using EIGENSTRAT or multidimensional scaling in PLINK.<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup> Additionally, individuals showing cryptic relatedness or having high levels of missingness or heterozygosity were excluded. All datasets were imputed to 1000 Genomes integrated variant set (March 2012) using IMPUTE v2.<sup><xref ref-type="bibr" rid="R20">20</xref></sup></p></sec><sec id="s1-6"><title>Genome-wide association analysis of WMHV in stroke patients.</title><p>To discover novel associations between WMHV and each autosomal SNP, we performed linear regression of WMHV on genotype dosages using PLINK v1.07.<sup><xref ref-type="bibr" rid="R19">19</xref></sup> SNPs with PLINK INFO &lt;0.7 or MAF &lt;0.01 were removed from further analyses. We used genomic inflation to evaluate inflation of test statistics in each study group.<sup><xref ref-type="bibr" rid="R21">21</xref></sup> Results across all study groups were combined using a fixed-effects inverse variance weighted method using METAL.<sup><xref ref-type="bibr" rid="R22">22</xref></sup> To control for any excess signal that might result from study-wise inflation of <italic>p</italic> values, we performed genomic control correction, multiplying the standard errors from each study by the square root of the genomic inflation factor.<sup><xref ref-type="bibr" rid="R21">21</xref></sup> Heterogeneity was assessed using Cochran <italic>q</italic> statistic. Following the meta-analysis, we considered only SNPs present in more than 12 study groups, and with heterogeneity <italic>p</italic> &gt; 0.001, for analysis. We set the significance threshold to <italic>p</italic> &lt; 5 × 10<sup>−8</sup>. We used λ<sub>1000</sub> to evaluate inflation at the meta-analysis level.<sup><xref ref-type="bibr" rid="R23">23</xref></sup> We had 80% power to detect a variant explaining 1.1% of the trait variance (figure e-1).</p></sec><sec id="s1-7"><title>Analysis of SNPs associated with WMH in community-based populations.</title><p>To determine whether SNPs contributing to WMHV in community populations were associated with WMHV in stroke patients, we evaluated each SNP reported as being associated with WMH in healthy adults in a recent publication,<sup><xref ref-type="bibr" rid="R12">12</xref></sup> testing if the SNP was associated with WMHV in ischemic stroke patients. All 17,936 individuals in the previous study were stroke-free and nonoverlapping with the samples studied here. We performed this analysis first for all genome-wide associated loci from the publication, and second for loci reported at <italic>p</italic> &lt; 1 ×10<sup>−5</sup> in European populations or overall. We set a significance threshold at <italic>p</italic> = 0.0033, Bonferroni correcting for the 15 SNPs analyzed. We had 80% power to detect any associations that explain 0.4% of the trait variance. In addition, we tested whether there was evidence overall that genetic susceptibility factors were shared between the 2 populations. We used a binomial test to evaluate whether an excess of the 8 genome-wide significant SNPs shared direction of effect in community populations and stroke patients, and then extended this to the 15 genome-wide significant loci and loci reported at <italic>p</italic> &lt; 1 × 10<sup>−5</sup> in European populations or overall.</p></sec><sec id="s1-8"><title>Meta-analysis of stroke samples and published population-based samples.</title><p>Having established that genetic factors were shared between community populations and stroke patients, we evaluated the overall evidence that each of the 15 previously reported SNPs (8 genome-wide significant, 7 suggestive) were associated with WMHV in both populations. We combined <italic>p</italic> values from the 2 sources using Stouffer <italic>z</italic>-score weighted method with equal weights, classifying SNPs with <italic>p</italic> &lt; 0.05 in both populations and reaching <italic>p</italic> &lt; 5 × 10<sup>−8</sup> overall as significantly associated with WMH in both populations. We were not able to perform the reciprocal analysis, testing if suggestive associations with WMH in stroke patients were associated with WMH in stroke-free individuals, due to restrictions on access to the required summary level data. We then evaluated novel genome-wide associations in available databases to test for evidence that affects regulation of genes (RegulomeDB)<sup><xref ref-type="bibr" rid="R24">24</xref></sup> or directly affects gene expression (GTEx).<sup><xref ref-type="bibr" rid="R25">25</xref></sup></p></sec></sec><sec id="s2" sec-type="results"><title>RESULTS</title><sec id="s2-1"><title>Study populations.</title><p>Clinical characteristics of all participating cohorts are given in <xref ref-type="table" rid="T1">table 1</xref>. In total, 3,670 individuals of European ancestry were included in the 19 study groups.</p></sec><sec id="s2-2"><title>Genome-wide association analysis of WMHV in stroke patients.</title><p>With the exception of one study group, genomic inflation was well-controlled (λ ≤ 1.03, <xref ref-type="table" rid="T1">table 1</xref>). Following quality control procedures, 7,567,914 autosomal SNPs remained for analysis. Genomic inflation was well-controlled at the meta-analysis level (λ = 1.04, λ<sub>1000</sub> = 1.01; figure e-2). No SNP reached the significance level (<xref ref-type="fig" rid="F1">figure 1</xref>), although a number of loci reached <italic>p</italic> &lt; 5 × 10<sup>−6</sup>. These are detailed in table e-3, and regional plots of these loci are provided in figure e-3. All odds ratios reported are per 1 SD change in normally distributed WMHV after accounting for age, sex, and ancestry-informative principal components.</p><fig id="F1" position="float"><label>Figure 1</label><caption><title>Association of genome-wide single nucleotide polymorphisms with white matter hyperintensity volume in ischemic stroke patients by genomic position</title></caption><graphic xlink:href="NEUROLOGY2015657247FF1"></graphic></fig></sec><sec id="s2-3"><title>Analysis of SNPs associated with WMH in community-based populations.</title><p>Eight independent SNPs have been associated with WMH in community populations.<sup><xref ref-type="bibr" rid="R12">12</xref></sup> We evaluated each of these in our dataset of stroke patients. The direction of effect of all 8 associations was consistent with the direction in our study. This alone is unlikely to be due to chance (<italic>p</italic> = 7.8 × 10<sup>−3</sup> from binomial test). For specific SNPs, no genome-wide associations from community populations reached our significance threshold, although all had <italic>p</italic> ≤ 0.24 for association with WMH in stroke patients, and 3 loci reached a nominal significance level (<italic>p</italic> &lt; 0.05) in stroke patients (rs7214628 [<italic>TRIM65</italic>], <italic>p</italic> = 0.015; rs78857879 [<italic>EFEMP1</italic>], <italic>p</italic> = 0.0056; rs2984613 [<italic>PMF1-BGLAP</italic>], <italic>p</italic> = 0.017).</p><p>Additionally, 10 loci were reported as suggestively significant in the same recent publication,<sup><xref ref-type="bibr" rid="R12">12</xref></sup> with <italic>p</italic> &lt; 1 × 10<sup>−5</sup> in Europeans or overall. Three of these were rare (MAF ≤ 0.02), and were not imputed with enough accuracy to be analyzed in our dataset (rs186314186, rs150695384, rs117126031). We evaluated each of the 7 remaining associations in our population. Of these, 4 passed our significance threshold (<xref ref-type="table" rid="T2">table 2</xref>). One locus was nonsignificant and in the opposite direction in our study (rs2883428, <italic>p</italic> = 0.17). In total, 14 of the 15 genome-wide and suggestively significant loci shared direction between community individuals and stroke patients (<italic>p</italic> = 9.8 × 10<sup>−4</sup> from binomial test).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Association of WMH-associated SNPs from community populations in stroke patients</p></caption><graphic xlink:href="NEUROLOGY2015657247TT2"></graphic></table-wrap><p>In addition, we searched for other publications describing associations with any of the SNPs or genes studied using the following search terms in PubMed: (SNP or gene) and (white matter or leukoaraiosis or small vessel disease). No relevant publications were identified.</p></sec><sec id="s2-4"><title>Meta-analysis of stroke samples and published population-based samples.</title><p>When combining our results in stroke patients with the 15 previously reported associations using Stouffer <italic>z</italic>-score meta-analysis, 6 associations reached genome-wide significance overall and had <italic>p</italic> &lt; 0.05 in both studies (<xref ref-type="table" rid="T2">table 2</xref>). Four of these are novel associations at genome-wide significance (rs72934505 [<italic>NBEAL1</italic>], <italic>p</italic> = 2.2 × 10<sup>−8</sup>; rs941898 [<italic>EVL</italic>], <italic>p</italic> = 4.0 × 10<sup>−8</sup>; rs962888 [<italic>C1QL1</italic>], <italic>p</italic> = 1.1 × 10<sup>−8</sup>; rs9515201 [<italic>COL4A2</italic>], <italic>p</italic> = 6.9 × 10<sup>−9</sup>), all of which showed good consistency across the 19 cohorts (figure e-4). The same 6 associations reached genome-wide significance using an alternative meta-analysis approach (Fisher method). The association with <italic>COL4A2</italic> (rs9515201) is in strong LD (r<sup>2</sup> &gt; 0.8) with SNPs previously reported to be associated with cerebral small vessel disease, and is therefore likely to represent the same locus.<sup><xref ref-type="bibr" rid="R26">26</xref></sup></p><p>For each of these 4 novel associations, we queried the RegulomeDB database and GTEx portal for evidence that the SNPs affect DNA binding or expression of any mRNA molecule (figure e-5).<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup> rs962888 lies 25 Kb downstream from <italic>C1QL1</italic>; however, interrogation of GTEx portal showed that the common allele (G, risk allele) of the SNP decreases expression of elongation factor tu GTP binding domain containing 2 (EFTUD2) in tibial arteries, 100 kb away (<italic>p</italic> = 5.3 × 10<sup>−6</sup>). Data from RegulomeDB support this observation, as the SNP overlies DNase-seq, FAIRE-seq, and CHIP-seq peaks in numerous tissues from ENCODE.<sup><xref ref-type="bibr" rid="R27">27</xref></sup> Similarly, the common allele (T, risk allele) of rs72934505 increases expression of the nearby gene <italic>NBEAL1</italic> in tibial arteries in GTEx (<italic>p</italic> = 2.5 × 10<sup>−11</sup>), and also decreases expression of islet cell autoantigen 1.69 kDa-Like (<italic>ICA1L</italic>) in the thyroid (<italic>p</italic> = 6.6 × 10<sup>−6</sup>), 200 kb away. No significant eQTLs were identified for rs941898 or rs9515201, but both overlap numerous CHIP-seq and DNAse-seq peaks from ENCODE, indicating they may have a regulatory function.</p></sec></sec><sec id="s3" sec-type="discussion"><title>DISCUSSION</title><p>We report the first phase of a collaborative genome-wide meta-analysis of WMHV in stroke patients. We did not identify any associations with WMHV in ischemic stroke patients at the genome-wide significance level. The most likely explanation for this is lack of power. We had 80% power to identify a variant explaining 1.1% of the trait variance (supplementary material), suggesting that it is unlikely that any common variants explain more than this proportion of the variance of WMH in stroke patients. However, we cannot rule out the existence of rare variants conferring a considerable proportion of disease risk.</p><p>We found strong evidence that many of the same genome-wide associations with WMHV in healthy individuals influence WMHV in stroke patients. All genome-wide significant associations with WMHV shared direction of effect in our study and 3 reached a nominal significance threshold. More convincing is that of the 7 suggestive associations reported with WMH in healthy individuals, 4 were significantly associated with WMH in stroke patients. A meta-analysis of these SNPs in 21,606 subjects suggests that 4 of these loci are linked to WMH in community populations and stroke patients at genome-wide significance. Two of these associations influence expression of nearby gene products (<italic>NBEAL1/ICA1L</italic> [rs72934505] and <italic>EFTUD2</italic> [rs962888]). A genome-wide significant association with rs9515201, located in an intron of <italic>COL4A2</italic>, which encodes collagen 4 subunit 2, was also identified. This association is particularly interesting as rare mutations in <italic>COL4A2</italic> and the closely related <italic>COL4A1</italic> protein lead to small vessel disease and hemorrhagic stroke,<sup><xref ref-type="bibr" rid="R28">28</xref><xref ref-type="bibr" rid="R29">–</xref><xref ref-type="bibr" rid="R30">30</xref></sup> and common variants in close LD with this SNP (<italic>r</italic><sup><italic>2</italic></sup> &gt; 0.8) have been linked to sporadic small vessel disease.<sup><xref ref-type="bibr" rid="R26">26</xref></sup></p><p>The observation that genetic risk factors for WMH in community populations also influence WMH in stroke patients has implications. It suggests that the white matter changes seen on the brain MRI scans of otherwise healthy elderly reflect a similar disease process as the more severe forms that underlie cerebral small vessel disease in patients with stroke. Previous studies have indicated heterogeneity in WMH pathology: our results do not preclude this possibility, but suggest that many of the same genetic factors contribute to both pathologies.</p><p>Our study has several strengths. Protocols were uniformly employed across analyses, including imputation to the same reference build across all study groups, using the same software. Similarly, analyses were performed using the same software on the same phenotype, derived in the same way. We performed volumetric analysis of all MRI scans to quantify WMHV, which has strengths over rating scales, which are known to have ceiling effects.<sup><xref ref-type="bibr" rid="R14">14</xref></sup> Inter-rater agreement between the 2 coordinating centers was shown to be good. WMHV was quantified using semiautomated volumetric protocols validated for use in patients with stroke and clinical grade MRI scans.</p><p>Our study also has limitations. Large-scale collaborative GWAS such as that undertaken here necessarily combine studies with some degree of phenotypic variability. Differences in environmental exposures, possibly resulting in epigenetic modifications, may contribute to such variability, which could alter the results. We identified 4 novel associations at genome-wide significance when combined with previous publications. However, we have not provided replication of these findings and therefore further evidence will be necessary to verify these associations with WMHV. MRI used in the analyses were drawn from a number of centers, with varying image quality. Therefore, to minimize bias arising from differing image quality, we quantified WMHV per study group and meta-analyzed the results. This approach may limit our ability to detect associations with low frequency variants due to small sample sizes in some study groups. The majority of MRI scans used were from FLAIR sequences. However, where these were unavailable, we used T2-weighted images, which are less sensitive to white matter changes. Such differences in sensitivity may affect quantification of WMHV across study groups, although future studies that involve centralized volumetric MRI analysis pipelines, such as those currently in development, may account for this variability. In this analysis, we considered all subtypes of stroke together as we were underpowered to investigate subtype-specific influences on WMH. It is possible that causes of WMH may differ by stroke subtype, but larger studies with sufficient power will be required before this issue can be addressed adequately. Similarly, it has been hypothesized that periventricular and deep WMH might have distinct underlying pathophysiology. In this analysis, we considered total WMHV, rather than treating these regions separately; our lesion volume analysis did not differentiate into these 2 regions. Further analyses should address this area.</p><p>We have shown that the age-related white matter changes seen in otherwise healthy populations share genetic susceptibility with the extensive lesions that underlie cerebral small vessel disease. We report 6 independent loci that are associated with WMHV in healthy individuals as well as stroke patients, 4 of which are novel associations at the genome-wide level. Our results suggest that a full genome-wide meta-analysis of available cohorts of WMH in ischemic stroke patients and community populations is likely to uncover further associations.</p></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="PMC_1">
<caption>
<title>Data Supplement</title>
</caption>
<media mime-subtype="html" mimetype="text" xlink:href="supp_86_2_146__index.html"></media>
<media mime-subtype="pdf" mimetype="application" xlink:href="supp_WNL.0000000000002263_e-tables.pdf" xlink:role="associated-file"></media>
<media mime-subtype="pdf" mimetype="application" xlink:href="supp_WNL.0000000000002263_Figure_e-1.pdf" xlink:role="associated-file"></media>
<media mime-subtype="pdf" mimetype="application" xlink:href="supp_WNL.0000000000002263_Figure_e-2.pdf" xlink:role="associated-file"></media>
<media mime-subtype="pdf" mimetype="application" xlink:href="supp_WNL.0000000000002263_Figure_e-3.pdf" xlink:role="associated-file"></media>
<media mime-subtype="pdf" mimetype="application" xlink:href="supp_WNL.0000000000002263_Figure_e-4.pdf" xlink:role="associated-file"></media>
<media mime-subtype="pdf" mimetype="application" xlink:href="supp_WNL.0000000000002263_Figure_e-5.pdf" xlink:role="associated-file"></media>
<media mime-subtype="pdf" mimetype="application" xlink:href="supp_WNL.0000000000002263_Supplementary_Materials.pdf" xlink:role="associated-file"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="PMC_2">
<caption>
<title>Coinvestigators</title>
</caption>
<media mime-subtype="html" mimetype="text" xlink:href="supp_86_2_146_v2_index.html"></media>
<media mime-subtype="msword" mimetype="application" xlink:href="supp_WNL.0000000000002263_Coinvestigators.docx" xlink:role="associated-file"></media>
</supplementary-material>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supplementary-material">
<p>Supplemental data at <ext-link ext-link-type="uri" xlink:href="http://neurology.org/lookup/doi/10.1212/WNL.0000000000002263">Neurology.org</ext-link></p>
</fn>
</fn-group>
<ack>
<title>ACKNOWLEDGMENT</title>
<p>The authors thank Kristiina Rannikmae for comments on the manuscript; and Wellcome Trust Case Control Consortium 2.</p>
</ack>
<sec>
<title>AUTHOR AFFILIATIONS</title>
<p>From the Department of Clinical Neurosciences (M.T., H.S.M.) and the Autism Research Centre (O.E.P.), University of Cambridge, UK; the J. Philip Kistler Stroke Research Center (C.R.Z., W.J.D., L.C., G.J.F., K.F., A.K., N.R.) and the Center for Human Genetic Research (W.J.D., G.J.F., F.R., J.R., N.R.), Department of Neurology, Massachusetts General Hospital, Boston; the Neurosciences Research Centre (P.A.-S., S.G., T.R.B., B.M.), St George's, University of London, UK; the Neurology Unit (S.L., J.R.), IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Program in Medical and Population Genetics (F.R.), Broad Institute, Cambridge, MA; the Department of Medical &amp; Molecular Genetics (C.M.L.) and the Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry (C.M.L.), King's College London, UK; the Department of Cerebrovascular Diseases (G.B.B.), Fondazione IRCCS Istituto Neurologico “Carlo Besta,” Milan, Italy; KU Leuven, University of Leuven, the Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (R.L., V.T.); University Hospitals Leuven, the Department of Neurology (R.L., V.T.); VIB, Vesalius Research Center, Laboratory of Neurobiology (R.L., V.T.), Leuven, Belgium; Austin Health and Melbourne Brain Center (V.T.), Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, Victoria, Australia; the Division of Clinical Neurosciences, Neuroimaging Sciences and Institute of Genetics and Molecular Medicine (C.S.), and Neuroimaging Sciences, Centre for Clinical Brain Sciences (J.W.), University of Edinburgh, UK; the Stroke Prevention Research Unit (P.M.R.), Nuffield Department of Neuroscience, University of Oxford, UK; the Department of Neurology (J.F.M.), Mayo Clinic, Jacksonville, FL; the Departments of Neurology and Public Health Sciences (B.B.W.), University of Virginia, Charlottesville; the Centre for Clinical Epidemiology and Biostatistics (C.L.), Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, NSW, Australia; School of Life Science (S.B.), University of Lincoln, Lincoln, UK; the Department of Neurology (K.L.F.), Rhode Island Hospital, Alpert Medical School of Brown University, Providence; the Institute for Stroke and Dementia Research (M.D.), Klinikum der Universität München, Ludwig-Maximilians-University Munich; and the Munich Cluster for Systems Neurology (SyNergy) (M.D.), Munich, Germany.</p>
</sec>
<sec sec-type="contributions">
<title>AUTHOR CONTRIBUTIONS</title>
<p content-type="contributions">Matthew Traylor: drafting/revising the manuscript for content, study concept or design, analysis or interpretation of data, statistical analysis, accepts responsibility for conduct of research and final approval. Cathy Zhang: drafting/revising the manuscript for content, study concept or design, analysis or interpretation of data, statistical analysis, accepts responsibility for conduct of research and final approval. Poneh Adib-Samii: drafting/revising the manuscript for content, study concept or design, analysis or interpretation of data, statistical analysis, accepts responsibility for conduct of research and final approval. William Devan: drafting/revising the manuscript for content, study concept or design, analysis or interpretation of data, statistical analysis, accepts responsibility for conduct of research and final approval. Owen Parsons: drafting/revising the manuscript for content, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. Silvia Lanfranconi: drafting/revising the manuscript for content, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. Sarah Gregory: drafting/revising the manuscript for content, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. Lisa Cloonan: drafting/revising the manuscript for content, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. Guido Falcone: drafting/revising the manuscript for content, accepts responsibility for conduct of research and final approval. Farid Radmanesh: drafting/revising the manuscript for content, accepts responsibility for conduct of research and final approval. Kaitlin Fitzpatrick: drafting/revising the manuscript for content, accepts responsibility for conduct of research and final approval. Alison Kanakis: drafting/revising the manuscript for content, accepts responsibility for conduct of research and final approval. Tom Barrick: drafting/revising the manuscript for content, accepts responsibility for conduct of research and final approval. Barry Moynihan: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Cathryn Lewis: drafting/revising the manuscript for content, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. Giorgio Boncoraglio: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Robin Lemmens: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Vincent Thijs: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Cathie Sudlow: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Joanna Wardlaw: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Peter Rothwell: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. James Meschia: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Bradford Worall: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Chris Levi: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Karen Furie: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Steve Bevan: drafting/revising the manuscript for content, analysis or interpretation of data, accepts responsibility for conduct of research and final approval. Martin Dichgans: drafting/revising the manuscript for content, acquisition of data, accepts responsibility for conduct of research and final approval. Jonathan Rosand: drafting/revising the manuscript for content, study concept or design, acquisition of data, analysis or interpretation of data, study supervision or coordination, accepts responsibility for conduct of research and final approval. Hugh Markus: drafting/revising the manuscript for content, study concept or design, acquisition of data, analysis or interpretation of data, study supervision or coordination, accepts responsibility for conduct of research and final approval. Natalia Rost: drafting/revising the manuscript for content, study concept or design, acquisition of data, analysis or interpretation of data, study supervision or coordination, accepts responsibility for conduct of research and final approval.</p>
</sec>
<sec sec-type="funding">
<title>STUDY FUNDING</title>
<p content-type="funding">Funding for collection, genotyping, and analysis of stroke samples was provided by <funding-source>Wellcome Trust</funding-source> Case Control Consortium–2, a functional genomics grant from the <funding-source>Wellcome Trust</funding-source> (DNA-Lacunar), the Stroke Association (DNA-Lacunar), the Intramural Research Program of National Institute of Ageing (Massachusetts General Hospital [MGH] and Ischemic Stroke Genetics Study [ISGS]), National Institute of Neurological Disorders and Stroke (Siblings With Ischemic Stroke Study, ISGS, and MGH), the <funding-source>American Heart Association</funding-source>/Bugher Foundation Centers for Stroke Prevention Research (MGH), Deane Institute for Integrative Study of Atrial Fibrillation and Stroke (MGH), <funding-source>National Health and Medical Research Council</funding-source> (Australian Stroke Genetics Collaborative), and <funding-source>Italian Ministry of Health (Milan)</funding-source>. Additional support for sample collection came from the <funding-source>Medical Research Council</funding-source>, <funding-source>National Institute of Health Research</funding-source> Biomedical Research Centre and Acute Vascular Imaging Centre (Oxford), <funding-source>Wellcome Trust</funding-source> and Binks Trust (Edinburgh), and <funding-source>Vascular Dementia Research Foundation (Munich)</funding-source>. M.T. is supported by a project grant from the Stroke Association (TSA 2013/01). H.S.M. is supported by an NIHR Senior Investigator award. H.S.M. and S.B. are supported by the NIHR Cambridge University Hospitals Comprehensive Biomedical Research Centre. V.T. and R.L. are supported by grants from FWO Flanders. P.R. holds NIHR and Wellcome Trust Senior Investigator Awards. P.A.S. is supported by an MRC Fellowship. C.M.L.'s research is supported by the National Institute for Health Research Biomedical Research Centre (BRC) based at Guy's and St Thomas' NHS Foundation Trust and King's College London, and the BRC for Mental Health at South London and Maudsley NHS Foundation Trust and King's College London.</p>
</sec>
<sec sec-type="disclosure">
<title>DISCLOSURE</title>
<p content-type="disclosure">The authors report no disclosures relevant to the manuscript. Go to <ext-link ext-link-type="uri" xlink:href="http://neurology.org/lookup/doi/10.1212/WNL.0000000000002263">Neurology.org</ext-link> for full disclosures.</p>
</sec>
<glossary>
<title>GLOSSARY</title>
<def-list>
<def-item>
<term id="G1">FLAIR</term>
<def>
<p>fluid-attenuated inversion recovery</p>
</def>
</def-item>
<def-item>
<term id="G2">ROI</term>
<def>
<p>region of interest</p>
</def>
</def-item>
<def-item>
<term id="G3">SNP</term>
<def>
<p>single nucleotide polymorphism</p>
</def>
</def-item>
<def-item>
<term id="G4">TICV</term>
<def>
<p>total intracranial volume</p>
</def>
</def-item>
<def-item>
<term id="G5">WMH</term>
<def>
<p>white matter hyperintensities</p>
</def>
</def-item>
<def-item>
<term id="G6">WMHV</term>
<def>
<p>white matter hyperintensity volume</p>
</def>
</def-item>
<def-item>
<term id="G7">WTCCC2</term>
<def>
<p>Wellcome Trust Case Control Consortium–2</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>Markus</surname><given-names>HS</given-names></name></person-group>
<article-title>The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis</article-title>. <source/>BMJ
<year>2010</year>;<volume>341</volume>:<comment>c3666</comment>.</mixed-citation>
</ref>
<ref id="R2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rost</surname><given-names>NS</given-names></name><name><surname>Rahman</surname><given-names>RM</given-names></name><name><surname>Biffi</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>White matter hyperintensity volume is increased in small vessel stroke subtypes</article-title>. <source/>Neurology
<year>2010</year>;<volume>75</volume>:<fpage>1670</fpage>–<lpage>1677</lpage>.<pub-id pub-id-type="pmid">21060091</pub-id></mixed-citation>
</ref>
<ref id="R3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ay</surname><given-names>H</given-names></name><name><surname>Arsava</surname><given-names>EM</given-names></name><name><surname>Rosand</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke</article-title>. <source/>Stroke
<year>2008</year>;<volume>39</volume>:<fpage>1409</fpage>–<lpage>1413</lpage>.<pub-id pub-id-type="pmid">18340093</pub-id></mixed-citation>
</ref>
<ref id="R4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arsava</surname><given-names>EM</given-names></name><name><surname>Rahman</surname><given-names>R</given-names></name><name><surname>Rosand</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke</article-title>. <source/>Neurology
<year>2009</year>;<volume>72</volume>:<fpage>1403</fpage>–<lpage>1410</lpage>.<pub-id pub-id-type="pmid">19380699</pub-id></mixed-citation>
</ref>
<ref id="R5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atwood</surname><given-names>LD</given-names></name><name><surname>Wolf</surname><given-names>PA</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><etal></etal></person-group>
<article-title>Genetic variation in white matter hyperintensity volume in the Framingham Study</article-title>. <source/>Stroke
<year>2004</year>;<volume>35</volume>:<fpage>1609</fpage>–<lpage>1613</lpage>.<pub-id pub-id-type="pmid">15143299</pub-id></mixed-citation>
</ref>
<ref id="R6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>ST</given-names></name><name><surname>Jack</surname><given-names>CR</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Mosley</surname><given-names>TH</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name></person-group>
<article-title>Heritability of leukoaraiosis in hypertensive sibships</article-title>. <source/>Hypertension
<year>2004</year>;<volume>43</volume>:<fpage>483</fpage>–<lpage>487</lpage>.<pub-id pub-id-type="pmid">14718359</pub-id></mixed-citation>
</ref>
<ref id="R7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmelli</surname><given-names>D</given-names></name><name><surname>DeCarli</surname><given-names>C</given-names></name><name><surname>Swan</surname><given-names>GE</given-names></name><etal></etal></person-group>
<article-title>Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins</article-title>. <source/>Stroke
<year>1998</year>;<volume>29</volume>:<fpage>1177</fpage>–<lpage>1181</lpage>.<pub-id pub-id-type="pmid">9626291</pub-id></mixed-citation>
</ref>
<ref id="R8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opherk</surname><given-names>C</given-names></name><name><surname>Peters</surname><given-names>N</given-names></name><name><surname>Holtmannspotter</surname><given-names>M</given-names></name><name><surname>Gschwendtner</surname><given-names>A</given-names></name><name><surname>Muller-Myhsok</surname><given-names>B</given-names></name><name><surname>Dichgans</surname><given-names>M</given-names></name></person-group>
<article-title>Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers</article-title>. <source/>Stroke
<year>2006</year>;<volume>37</volume>:<fpage>2684</fpage>–<lpage>2689</lpage>.<pub-id pub-id-type="pmid">17008614</pub-id></mixed-citation>
</ref>
<ref id="R9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adib-Samii</surname><given-names>P</given-names></name><name><surname>Devan</surname><given-names>W</given-names></name><name><surname>Traylor</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic stroke</article-title>. <source/>Stroke
<year>2015</year>;<volume>46</volume>:<fpage>348</fpage>–<lpage>353</lpage>.<pub-id pub-id-type="pmid">25550368</pub-id></mixed-citation>
</ref>
<ref id="R10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><etal></etal></person-group>
<article-title>Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium</article-title>. <source/>Ann Neurol
<year>2011</year>;<volume>69</volume>:<fpage>928</fpage>–<lpage>939</lpage>.<pub-id pub-id-type="pmid">21681796</pub-id></mixed-citation>
</ref>
<ref id="R11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>LM</given-names></name><name><surname>Hill</surname><given-names>WD</given-names></name><name><surname>Harris</surname><given-names>SE</given-names></name><etal></etal></person-group>
<article-title>Genes from a translational analysis support a multifactorial nature of white matter hyperintensities</article-title>. <source/>Stroke
<year>2015</year>;<volume>46</volume>:<fpage>341</fpage>–<lpage>347</lpage>.<pub-id pub-id-type="pmid">25586835</pub-id></mixed-citation>
</ref>
<ref id="R12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhaaren</surname><given-names>BF</given-names></name><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><etal></etal></person-group>
<article-title>Multi-ethnic genome-wide association study of cerebral white matter hyperintensities on MRI</article-title>. <source/>Circ Cardiovasc Genet
<year>2015</year>;<volume>8</volume>:<fpage>398</fpage>–<lpage>409</lpage>.<pub-id pub-id-type="pmid">25663218</pub-id></mixed-citation>
</ref>
<ref id="R13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Haybaeck</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Heterogeneity in age-related white matter changes</article-title>. <source/>Acta Neuropathol
<year>2011</year>;<volume>122</volume>:<fpage>171</fpage>–<lpage>185</lpage>.<pub-id pub-id-type="pmid">21706175</pub-id></mixed-citation>
</ref>
<ref id="R14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wardlaw</surname><given-names>JM</given-names></name><name><surname>Smith</surname><given-names>EE</given-names></name><name><surname>Biessels</surname><given-names>GJ</given-names></name><etal></etal></person-group>
<article-title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration</article-title>. <source/>Lancet Neurol
<year>2013</year>;<volume>12</volume>:<fpage>822</fpage>–<lpage>838</lpage>.<pub-id pub-id-type="pmid">23867200</pub-id></mixed-citation>
</ref>
<ref id="R15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Gurol</surname><given-names>ME</given-names></name><name><surname>Rosand</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy</article-title>. <source/>Neurology
<year>2006</year>;<volume>67</volume>:<fpage>83</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">16832082</pub-id></mixed-citation>
</ref>
<ref id="R16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimaud</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>M</given-names></name><name><surname>Thorpe</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques</article-title>. <source/>Magn Reson Imaging
<year>1996</year>;<volume>14</volume>:<fpage>495</fpage>–<lpage>505</lpage>.<pub-id pub-id-type="pmid">8843362</pub-id></mixed-citation>
</ref>
<ref id="R17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jenkinson</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Accurate, robust, and automated longitudinal and cross-sectional brain change analysis</article-title>. <source/>Neuroimage
<year>2002</year>;<volume>17</volume>:<fpage>479</fpage>–<lpage>489</lpage>.<pub-id pub-id-type="pmid">12482100</pub-id></mixed-citation>
</ref>
<ref id="R18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Patterson</surname><given-names>NJ</given-names></name><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Weinblatt</surname><given-names>ME</given-names></name><name><surname>Shadick</surname><given-names>NA</given-names></name><name><surname>Reich</surname><given-names>D</given-names></name></person-group>
<article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>. <source/>Nat Genet
<year>2006</year>;<volume>38</volume>:<fpage>904</fpage>–<lpage>909</lpage>.<pub-id pub-id-type="pmid">16862161</pub-id></mixed-citation>
</ref>
<ref id="R19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source/>Am J Hum Genet
<year>2007</year>;<volume>81</volume>:<fpage>559</fpage>–<lpage>575</lpage>.<pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation>
</ref>
<ref id="R20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><etal></etal></person-group>
<article-title>An integrated map of genetic variation from 1,092 human genomes</article-title>. <source/>Nature
<year>2012</year>;<volume>491</volume>:<fpage>56</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">23128226</pub-id></mixed-citation>
</ref>
<ref id="R21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Roeder</surname><given-names>K</given-names></name></person-group>
<article-title>Genomic control for association studies</article-title>. <source/>Biometrics
<year>1999</year>;<volume>55</volume>:<fpage>997</fpage>–<lpage>1004</lpage>.<pub-id pub-id-type="pmid">11315092</pub-id></mixed-citation>
</ref>
<ref id="R22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group>
<article-title>METAL: fast and efficient meta-analysis of genomewide association scans</article-title>. <source/>Bioinformatics
<year>2010</year>;<volume>26</volume>:<fpage>2190</fpage>–<lpage>2191</lpage>.<pub-id pub-id-type="pmid">20616382</pub-id></mixed-citation>
</ref>
<ref id="R23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>PI</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name></person-group>
<article-title>Practical aspects of imputation-driven meta-analysis of genome-wide association studies</article-title>. <source/>Hum Mol Genet
<year>2008</year>;<volume>17</volume>:<fpage>R122</fpage>–<lpage>R128</lpage>.<pub-id pub-id-type="pmid">18852200</pub-id></mixed-citation>
</ref>
<ref id="R24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>AP</given-names></name><name><surname>Hong</surname><given-names>EL</given-names></name><name><surname>Hariharan</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Annotation of functional variation in personal genomes using RegulomeDB</article-title>. <source/>Genome Res
<year>2012</year>;<volume>22</volume>:<fpage>1790</fpage>–<lpage>1797</lpage>.<pub-id pub-id-type="pmid">22955989</pub-id></mixed-citation>
</ref>
<ref id="R25">
<label>25.</label>
<mixed-citation publication-type="journal"><article-title>The Genotype-Tissue Expression (GTEx) Project</article-title>. <source/>Nat Genet
<year>2013</year>;<volume>45</volume>:<fpage>580</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">23715323</pub-id></mixed-citation>
</ref>
<ref id="R26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rannikmae</surname><given-names>K</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Thomson</surname><given-names>PA</given-names></name><etal></etal></person-group>
<article-title>Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease</article-title>. <source/>Neurology
<year>2015</year>;<volume>84</volume>:<fpage>918</fpage>–<lpage>926</lpage>.<pub-id pub-id-type="pmid">25653287</pub-id></mixed-citation>
</ref>
<ref id="R27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham</surname><given-names>I</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Aldred</surname><given-names>SF</given-names></name><etal></etal></person-group>
<article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>. <source/>Nature
<year>2012</year>;<volume>489</volume>:<fpage>57</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">22955616</pub-id></mixed-citation>
</ref>
<ref id="R28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>DB</given-names></name><name><surname>Phalan</surname><given-names>FC</given-names></name><name><surname>van Mil</surname><given-names>SE</given-names></name><etal></etal></person-group>
<article-title>Role of COL4A1 in small-vessel disease and hemorrhagic stroke</article-title>. <source/>N Engl J Med
<year>2006</year>;<volume>354</volume>:<fpage>1489</fpage>–<lpage>1496</lpage>.<pub-id pub-id-type="pmid">16598045</pub-id></mixed-citation>
</ref>
<ref id="R29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanfranconi</surname><given-names>S</given-names></name><name><surname>Markus</surname><given-names>HS</given-names></name></person-group>
<article-title>COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review</article-title>. <source/>Stroke
<year>2010</year>;<volume>41</volume>:<fpage>e513</fpage>–<lpage>e518</lpage>.<pub-id pub-id-type="pmid">20558831</pub-id></mixed-citation>
</ref>
<ref id="R30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeanne</surname><given-names>M</given-names></name><name><surname>Labelle-Dumais</surname><given-names>C</given-names></name><name><surname>Jorgensen</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke</article-title>. <source/>Am J Hum Genet
<year>2012</year>;<volume>90</volume>:<fpage>91</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">22209247</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>